A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer

Clinical trial NCT03215511 · COMPLETED

Trial details

NCT number: NCT03215511
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Harboring NTRK Fusion

Start date: 2017-07-03
Primary completion: 2022-04-11
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.